NEW YORK (GenomeWeb) – The Medical Research Council on Thursday announced a £16 million ($27 million) research project into dementia that includes the development of new biomarkers for identifying those at risk for developing the condition and patients who may be candidates for new drug trials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.